AR056674A1 - Anticoncepcion oral con trimegestona - Google Patents
Anticoncepcion oral con trimegestonaInfo
- Publication number
- AR056674A1 AR056674A1 ARP060103101A ARP060103101A AR056674A1 AR 056674 A1 AR056674 A1 AR 056674A1 AR P060103101 A ARP060103101 A AR P060103101A AR P060103101 A ARP060103101 A AR P060103101A AR 056674 A1 AR056674 A1 AR 056674A1
- Authority
- AR
- Argentina
- Prior art keywords
- trimegestone
- oral contraception
- contraception
- successive days
- woman
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Método para la anticoncepcion que comprende la administracion de trimegestona junto con etinilestradiol a una mujer en edad fértil en al menos 21 días sucesivos, comenzando el día 1 del ciclo menstrual, en el que en al menos uno de los al menos 21 días sucesivos la dosis diaria de trimegestona es superior a 500 ?g.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005034498A DE102005034498A1 (de) | 2005-07-20 | 2005-07-20 | Orale Kontrazeption mit Trimegeston |
US11/348,545 US20070021396A1 (en) | 2005-07-20 | 2006-02-06 | Oral contraception with trimegestone |
Publications (1)
Publication Number | Publication Date |
---|---|
AR056674A1 true AR056674A1 (es) | 2007-10-17 |
Family
ID=37075980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103101A AR056674A1 (es) | 2005-07-20 | 2006-07-19 | Anticoncepcion oral con trimegestona |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1909799A1 (es) |
KR (1) | KR20080031435A (es) |
AR (1) | AR056674A1 (es) |
AU (1) | AU2006271920A1 (es) |
CA (1) | CA2615427A1 (es) |
WO (1) | WO2007009769A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004246A2 (en) * | 1996-07-26 | 1998-02-05 | American Home Prod | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
FR2801218B1 (fr) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant |
-
2006
- 2006-07-19 WO PCT/EP2006/007103 patent/WO2007009769A1/en active Application Filing
- 2006-07-19 EP EP06762699A patent/EP1909799A1/en not_active Withdrawn
- 2006-07-19 AU AU2006271920A patent/AU2006271920A1/en not_active Abandoned
- 2006-07-19 CA CA002615427A patent/CA2615427A1/en not_active Abandoned
- 2006-07-19 AR ARP060103101A patent/AR056674A1/es unknown
- 2006-07-19 KR KR1020087004095A patent/KR20080031435A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006271920A1 (en) | 2007-01-25 |
WO2007009769A1 (en) | 2007-01-25 |
CA2615427A1 (en) | 2007-01-25 |
EP1909799A1 (en) | 2008-04-16 |
KR20080031435A (ko) | 2008-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
AR054525A1 (es) | Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo | |
ES2693085T1 (es) | Uso de estriol en bajas dosis | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
AR032204A1 (es) | Complejos de inclusion de ciclodextrina-drospirenona | |
RS53876B1 (en) | PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS | |
BR0313921A (pt) | Regime de reposição de estrogênio | |
HN2008000621A (es) | Metodo para la anticopcepcion hormonal preventiva bajo demanda | |
EA201400202A1 (ru) | Применение эстетрола в качестве экстренного контрацептива | |
PE20061314A1 (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
UY30461A1 (es) | Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas. | |
PE20211588A1 (es) | Compuestos y sus usos para aliviar sintomas asociados a la menopausia | |
AR065816A1 (es) | Regimen anticonceptivo oral | |
ES2563068T3 (es) | Tratamiento de esclerosis múltiple (MS) con Campath-1H | |
CO2019000604A2 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d | |
GT200900296A (es) | Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante. | |
ES2574999T3 (es) | Método para la contracepción a demanda usando levonorgestrel o norgestrel | |
UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
AR056674A1 (es) | Anticoncepcion oral con trimegestona | |
AR080541A1 (es) | Tratamiento para la endometriosis | |
AR044831A1 (es) | Forma de administracion inyectable de la flupirtina | |
AR057155A1 (es) | Metodo de administracion de la 5-(2-clorofenil)-1,2-dihidro-7-fluor-8-metoxi-3-metil-pirazolo[3,4-b][1,4]benzodiazepina | |
PA8624501A1 (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |